Navegar

Colección

Datos Estadísticas

Lista de

Allosteric Regulation
13
"Understanding the molecular basis of the high oxygen affinity variant human hemoglobin Coimbra" (2018) Jorge, S.E.;Bringas, M.;Petruk, A.A. (...)Estrin, D. Archives of Biochemistry and Biophysics. 637:73-78
"Quercetin antagonism of GABAAρ1 receptors is prevented by ascorbic acid through a redox-independent mechanism" (2013) Calero, C.I.;González, A.N.B.;Gasulla, J. (...)Calvo, D.J. European Journal of Pharmacology. 714(1-3):274-280
"Quercetin antagonism of GABAAρ1 receptors is prevented by ascorbic acid through a redox-independent mechanism" (2013) Calero, C.I.;González, A.N.B.;Gasulla, J. (...)Calvo, D.J. European Journal of Pharmacology. 714(1-3):274-280
"The allosteric modulation of thyroxine-binding globulin affinity is entropy driven" (2013) Petruk, A.A.; Labanda, M.S.; Álvarez, R.M.S.; Marti, M.A. Biochimica et Biophysica Acta - General Subjects. 1830(6):3570-3577
"Load-induced modulation of signal transduction networks" (2011) Jiang, P.;Ventura, A.C.;Sontag, E.D. (...)Del Vecchio, D. Science Signaling. 4(194)
"On the role of frustration in the energy landscapes of allosteric proteins" (2011) Ferreiro, D.U.; Hegler, J.A.; Komives, E.A.; Wolynes, P.G. Proceedings of the National Academy of Sciences of the United States of America. 108(9):3499-3503
"P38γ activation triggers dynamical changes in allosteric docking sites" (2011) Rodriguez Limardo, R.G.;Ferreiro, D.N.;Roitberg, A.E. (...)Turjanski, A.G. Biochemistry. 50(8):1384-1395
"Key roles of hydrophobic rings of TM2 in gating of the α9α10 nicotinic cholinergic receptor" (2005) Plazas, P.V.;De Rosa, M.J.;Gomez-Casati, M.E. (...)Elgoyhen, A.B. British Journal of Pharmacology. 145(7):963-974
"Two different intrachain cAMP sites in the cAMP‐dependent protein kinase of the dimorphic fungus Mucor rouxii" (1989) Paveto, C.; Passeron, S.; Corbin, J.D.; Moreno, S. European Journal of Biochemistry. 179(2):429-434
"Allosteric transition of erythrocyte alkaline phosphatase from duchenne muscular dystrophy (DMD) patients and duchenne muscular dystrophy carriers (Homo sapiens)" (1988) Goldemberg, A.L.;García, A.M.;Fernández, H. (...)Trucco, R.E. International Journal of Biochemistry. 20(7):703-706
"Stabilization of different conformational states of liver pyruvate kinase type L by the allosteric activators" (1973) Rozengurt, E.; De Asua, L.J.; Carminatti, H. FEBS Letters. 37(2):225-227